Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 4/20 | 0.46 |
| ▸ | ACACB | O00763 | 1/20 | 0.44 |
| ▸ | LPL | P06858 | 4/20 | 0.43 |
| ▸ | LIPG | Q9Y5X9 | 4/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.42 |
| ▸ | MLYCD | O95822 | 2/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | ESRRG | P62508 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28504646 | 0.86 | HDAC4 (0.46) | LPLLIPGMLYCDHDAC6DRD2 | |
| SCHEMBL490705 | 0.86 | LPL (0.44) | NAMPTLPLLIPGPDK2MLYCD | |
| SCHEMBL12538103 | 0.84 | MLYCD (0.58) | LPLLIPGEGFRERBB2MLYCD | |
| SCHEMBL28499683 | 0.83 | HDAC6 (0.43) | MLYCDHDAC6ALDH1A1DRD2ESRRG | |
| SCHEMBL22858927 | 0.81 | ALDH1A1 (0.50) | MLYCDALDH1A1 | |
| SCHEMBL4495603 | 0.80 | ESRRG (0.56) | NAMPTACACBEGFRERBB2PDK2 | |
| SCHEMBL21077963 | 0.80 | CDK4 (0.50) | NAMPTACACBEGFRERBB2PDK2 | |
| SCHEMBL177498 | 0.80 | MLYCD (0.64) | NAMPTMLYCDESRRG | |
| SCHEMBL28513496 | 0.80 | DRD2 (0.44) | NAMPTMLYCDHDAC6ALDH1A1DRD2 | |
| SCHEMBL4022759 | 0.79 | DPP4 (0.40) | LPLLIPGHDAC6CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230338415-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | GLYSCEND, INC. | 2023-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230338415-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | SLC10A2, PYGL, SLC10A1 | NAMPT 1229/4885ACACB 1244/4885LPL 960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.